Literature DB >> 21052035

Subretinal dot-like precipitates and yellow material in central serous chorioretinopathy.

Ichiro Maruko1, Tomohiro Iida, Akira Ojima, Tetsuju Sekiryu.   

Abstract

PURPOSE: Multiple, dot-like, yellow precipitates and subretinal yellow material are sometimes deposited within the area of a serous retinal detachment in central serous chorioretinopathy. We report the incidence and clinical features of these depositions in central serous chorioretinopathy.
METHODS: Eighty eyes of 75 patients (average age, 50.2 years) with central serous chorioretinopathy were studied retrospectively. Fundus autofluorescence and optical coherence tomography findings were evaluated. Precipitates were defined as those ≤ 63 μm in diameter and subretinal yellow material >63 μm.
RESULTS: The mean follow-up period was 17.6 months. Forty-five eyes (56.3%) had dot-like precipitates, and 40 eyes (50.0%) had subretinal yellow material. Fifty-two of 80 eyes (65.0%) had both or at least one of them; of these 52 eyes, 50 eyes (96.2%) had hyperautofluorescence and 42 eyes (80.8%) had high reflectivity on optical coherence tomography. The depositions in 23 eyes were not hyperautofluorescent at the initial examination, but the hyperautofluorescence developed during the follow-up period.
CONCLUSION: Dot-like precipitates and subretinal yellow material were seen in 65% of cases with central serous chorioretinopathy that also showed high reflectivity on optical coherence tomography and hyperautofluorescence during follow-up. These findings may indicate that these formations are associated with shedding of the photoreceptor outer segments and metabolism by phagocytes.

Entities:  

Mesh:

Year:  2011        PMID: 21052035     DOI: 10.1097/IAE.0b013e3181fbce8e

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  19 in total

1.  Acute central serous chorioretinopathy: a correlation study between fundus autofluorescence and spectral-domain OCT.

Authors:  Pierluigi Iacono; Parodi Maurizio Battaglia; Alexandros Papayannis; Carlo La Spina; Monica Varano; Francesco Bandello
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-01-08       Impact factor: 3.117

Review 2.  Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors:  Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal:  Surv Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 6.048

3.  Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).

Authors:  Timothy Y Y Lai; Raymond L M Wong; Wai-Man Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2015

4.  Comparison of photodynamic therapy and navigated microsecond laser for chronic central serous chorioretinopathy.

Authors:  Cyprian Gabriel Ntomoka; Bindu Rajesh; Gachago Muchai Muriithi; Abhilash Goud; Jay Chhablani
Journal:  Eye (Lond)       Date:  2018-02-12       Impact factor: 3.775

5.  Hyperreflective foci in the choroid of normal eyes.

Authors:  Young Ho Kim; Jaeryung Oh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-10-21       Impact factor: 3.117

6.  Type one macular neovascularization in central serous chorioretinopathy: Short-term response to anti-vascular endothelial growth factor therapy.

Authors:  Raphaël Lejoyeux; Francine Behar-Cohen; Irmela Mantel; Jorge Ruiz-Medrano; Sarah Mrejen; Ramin Tadayoni; Alain Gaudric; Elodie Bousquet
Journal:  Eye (Lond)       Date:  2021-09-28       Impact factor: 4.456

7.  Fundus autofluorescence imaging patterns in central serous chorioretinopathy according to chronicity.

Authors:  W J Lee; J-H Lee; B R Lee
Journal:  Eye (Lond)       Date:  2016-06-10       Impact factor: 3.775

Review 8.  [Central serous chorioretinopathy].

Authors:  Laurenz Pauleikhoff; Hansjürgen Agostini; Clemens Lange
Journal:  Ophthalmologe       Date:  2021-04-16       Impact factor: 1.059

9.  Fundus autofluorescence and optical coherence tomography findings in branch retinal vein occlusion.

Authors:  Tetsuju Sekiryu; Tomohiro Iida; Eiichi Sakai; Ichiro Maruko; Akira Ojima; Yukinori Sugano
Journal:  J Ophthalmol       Date:  2012-11-13       Impact factor: 1.909

Review 10.  Advances in the treatment of central serous chorioretinopathy.

Authors:  Marwan A Abouammoh
Journal:  Saudi J Ophthalmol       Date:  2015-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.